BEIJING (Reuters) - A powerful U.S. senator said he is concerned that state-owned ChemChina, which is buying Swiss crop protection and seed group Syngenta for $43 billion, could use U.S. sovereign immunity laws to shield itself from claims in U.S. courts.

Key U.S. senator remains concerned over ChemChina-Syngenta deal
Read More
Bagikan Berita Ini
0 Response to "Key U.S. senator remains concerned over ChemChina-Syngenta deal"
Posting Komentar